Following a “strict safety check”, the British Medicines Agency (MHRA) has extended its license Pfizer / BioNtech vaccine against Covid-19 in adolescents 12 to 15 years of age.
“We carefully examined the clinical trial data in children 12 to 15 years of age and concluded that the Pfizer / BioNtech vaccine against Covid-19 is safe and effective at this age,” said MHRA Director-General June Raine. club”.
She adds, according to the Athens News Agency, that “the benefits of this vaccine outweigh any risks.”
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
